ARCHIVES

Clinical Trials: For ER+ Breast Cancer, Post-Tamoxifen, NSABP Testing Aromasin In Large Trial

This article is from The Cancer Letter archive.

Vol. 27 No. 22 | June 1, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: Taxol Development Is NCI ‘Emergency Priority’, Dodd To Focus ACS Effort On Breast Screening

December 7, 1990

In Their Own Words: “Blessed with The Opportunity” vs. “LOWEST Morale Ever”

May 23, 2014

Bill Promotes Awareness Of Pediatric Cancer Research.

September 22, 2000

In Brief: FDA Approves Two Alpha Interferons; Canellos to Give Schwartz Lecture At Scripps Meeting

June 13, 1986

Newell Describes Progress To House, Senate Subcommittees

March 25, 1977

FDA Advisors Okay NCI Toxicology Proposals, Write New Clinical Guidelines, Approve AIN DA

October 19, 1979